News

All the news at a glance

We value candid dialog and transparent communication. It goes without saying that we regularly inform our customers, shareholders and the public about the most important developments at our company. You can choose from different news types such as articleseventswebcasts and webinarsreports or ad-hoc announcements.

85 results For "healthcare" Clear filter

Annual Results 2025
Ad hoc announcement | Feb 12, 2026

In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.

Launch of 20mL Universal Plunger
Article | Jan 21, 2026

Datwyler expanded its NeoFlex™ range of fully coated plungers with a solution for large-volume cartridges containing 20mL. The launch responds to rising demand for on-body devices for subcutaneous (SC) delivery of biotherapeutics to patients seeking convenient at-home care.

Collaboration Datwyler, LTS Device Technologies and Stevanato Group
Article | Jan 16, 2026

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

1st place for Datwyler at the Swiss Employer Award 2026
News | Jan 16, 2026

The Swiss Datwyler site in Schattdorf, Switzerland, took 1st place in the Swiss Arbeitgeber Award 2026 in the category for large companies (250–999 employees).

Capital Markets Day 2025
Ad hoc announcement | Nov 19, 2025

With its clear focus on high‑value components and strengthening its core competencies, Datwyler is strategically well positioned to benefit from long‑term growth trends.

Introduction Flip Caps with Bio-sourced Materials
Article | Oct 28, 2025

Datwyler is proud to unveil a new option in its flip cap range: a bio-sourced material for the plastic disc, debuting at CPhI Worldwide 2025.

Half-Year Results 2025
Ad hoc announcement | Jul 22, 2025

Datwyler gained momentum in the first half of 2025 despite a challenging environment.

Start of serial component supply for GLP-1 therapy
News | Apr 2, 2025

Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.

AGM 2025
Annual General Meeting | Mar 19, 2025

The 67th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 18 March 2025.

Planet Water Impact Report 2024
News | Feb 14, 2025

Dätwyler arbeitet seit mehreren Jahren mit der Nichtregierungsorganisation Planet Water zusammen, um den Zugang zu sauberem Trinkwasser in Maharashtra, Indien, zu verbessern.

Annual Results 2024
Ad hoc announcement | Feb 6, 2025

Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.

Launch Transformation Program ForwardNow
Ad hoc announcement | Dec 18, 2024

Datwyler is launching a transformation program for the period 2025 to 2027 to accelerate revenue and profitability growth.

Launch of NeoFlex™ Plungers for Large Volume Biologics
News | Oct 8, 2024

Datwyler announces the expansion of its NeoFlex™ range of coated plungers with new sizes for containers aimed at large-volume auto-injectors and wearable devices.

Britt Hendriksen nominated for Board of Directors
News | Oct 3, 2024

The Board of Dätwyler Holding Inc. has decided to nominate Britt Hendriksen for election as a new member of the Board and as a representative of the public shareholders at the Annual General Meeting on 18 March 2025.

Half-Year Results 2024
Ad hoc announcement | Jul 23, 2024

Despite a weak market environment, Datwyler improved its profitability and further strengthened its project pipeline in the first half of 2024.

Annual Results 2023
Ad hoc announcement | Feb 7, 2024

Datwyler was able to maintain revenue in 2023 despite the loss of the Covid business and destocking by customers. The strong project pipeline provides the basis for scaling the business model.

Bronze at the Swiss Employer Award 2024
Human Resources | Jan 29, 2024

The Datwyler site in Schattdorf took third place in the large company category (250-999 employees) of the Swiss Employer Award 2024.

New healthcare distribution partner in the UK
News | Dec 13, 2023

Datwyler is teaming up with Conserva UK to establish an unrivaled supply chain for pharmaceutical primary packaging in the UK market.